← Back to Search

WeCareAdvisor for Caregiver Support in Dementia

N/A
Recruiting
Led By Laura N Gitlin, PhD
Research Sponsored by Drexel University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will help caregivers manage behavioral and psychological symptoms of dementia and reduce caregiver distress.

Who is the study for?
This trial is for primary caregivers who have been caring for someone with dementia for at least 6 months, can use a smartphone or computer with internet, and speak English. They must not be planning to move the person into long-term care soon, be in another similar study, or have severe visual/hearing impairments.Check my eligibility
What is being tested?
The WeCareAdvisor online tool is being tested to see if it helps caregivers manage dementia-related behaviors better. Caregivers are split into groups: some get immediate prompts from the tool; others wait three months before starting. The intensity of these prompts varies between high and low.See study design
What are the potential side effects?
Since this trial involves an online tool rather than medication, traditional side effects aren't expected. However, using the tool could potentially lead to increased screen time which might affect sleep patterns or cause eye strain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Long-Term Change in Caregiver Confidence Managing Behavioral and Psychological Symptoms of Dementia
Long-Term Change in Person Living with Dementia- Frequency and Severity of Behaviors
Long-term Change in Caregiver Distress with Behaviors (3-Months)
+3 more
Secondary outcome measures
Change in Person with Dementia's Medications
Long Term Change in Caregiver Wellbeing
Long Term Change in Caregiver- Negative Communications
+9 more

Trial Design

4Treatment groups
Experimental Treatment
Group I: Waitlist Control after three months with high-Intensity promptsExperimental Treatment1 Intervention
After three months, caregivers will receive WeCareAdvisor and telephone and email prompts.
Group II: Waitlist Control after three months with Low-Intensity PromptsExperimental Treatment1 Intervention
After three months, caregivers will receive WeCareAdvisor and email prompts only.
Group III: Immediate treatment group with Low-Intensity PromptsExperimental Treatment1 Intervention
Caregivers will use the WeCareAdvisor tool for six months and receive email prompts only.
Group IV: Immediate treatment group with High-Intensity PromptsExperimental Treatment1 Intervention
Caregivers will use the WeCareAdvisor tool for six months and receive telephone and email prompts.

Find a Location

Who is running the clinical trial?

Drexel UniversityLead Sponsor
150 Previous Clinical Trials
47,439 Total Patients Enrolled
3 Trials studying Dementia
241 Patients Enrolled for Dementia
University of California, DavisOTHER
911 Previous Clinical Trials
4,709,257 Total Patients Enrolled
9 Trials studying Dementia
3,229 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,671 Previous Clinical Trials
28,016,737 Total Patients Enrolled
266 Trials studying Dementia
23,625,034 Patients Enrolled for Dementia

Media Library

WeCareAdvisor Study Clinical Trial Eligibility Overview. Trial Name: NCT05012410 — N/A
Dementia Research Study Groups: Immediate treatment group with High-Intensity Prompts, Immediate treatment group with Low-Intensity Prompts, Waitlist Control after three months with Low-Intensity Prompts, Waitlist Control after three months with high-Intensity prompts
Dementia Clinical Trial 2023: WeCareAdvisor Study Highlights & Side Effects. Trial Name: NCT05012410 — N/A
WeCareAdvisor Study 2023 Treatment Timeline for Medical Study. Trial Name: NCT05012410 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many volunteers are contributing to this experiment?

"Affirmative. Data from clinicaltrials.gov indicates that this medical trial, initiated on December 7th 2021, is actively seeking participants. Approximately 326 patients must be enrolled at a single site for the study to proceed as planned."

Answered by AI

What results is this trial hoping to accomplish?

"The key outcome being assessed over the course of roughly one month is Long-term Change in Caregiver Distress with Behaviors (3-Months). Secondary objectives comprise Short Term Change in Caregiver Negative Communications, amounting to 6 items from various scales that measure frequency of use; Long-Term Term Change in Person with Dementia Level of Physical Dependence which uses the Functional Assessment Staging Scale, and Utilization of tool use determined by dashboard data."

Answered by AI

Are any openings available for participants of this clinical trial?

"Affirmative. According to clinicaltrials.gov, this scientific experiment was initially published on December 7th 2021 and is actively recruiting participants at present. The study needs 326 people from a single location for participation."

Answered by AI
Recent research and studies
~86 spots leftby Mar 2025